RNA editing is vital for neurodevelopment and the maintenance of normal neuronal function. We surveyed the global landscape and genetic regulation of RNA editing across several hundred schizophrenia and control postmortem brain samples from the CommonMind Consortium covering two regions, the dorsolateral prefrontal cortex (DLPFC) and anterior cingulate cortex. In schizophrenia, RNA editing sites encoding AMPA glutamate receptors and post-synaptic density genes were less edited, while more editing was detected in sites implicated in translational initiation. These sites replicate between brain regions, map to 3'UTRs, enrich for common sequence motifs and coincide for RNA binding proteins crucial for neurodevelopment. Importantly, these findings cross-validate in hundreds of non-overlapping DLPFC samples. Furthermore, ~30% of RNA editing sites associate with cis-regulatory variants (edQTLs). Fine-mapping edQTLs with schizophrenia GWAS loci revealed colocalization of 11 edQTLs with 6 GWAS loci. This supports a causal role of RNA editing in risk for schizophrenia. Our findings illustrate widespread altered RNA editing in schizophrenia and its genetic regulation, and shed light onto RNA editing-mediated mechanisms in schizophrenia neuropathology.
INTRODUCTION
Schizophrenia (SCZ) is a severe psychiatric disorder affecting ca. 0.7% of adults that is 3 characterized by abnormalities in thought and cognition 1 and >100 common genetic loci 6 , the latter exerting small polygenetic effects on disease risk. This 9 observation of a highly polygenic architecture has been widely replicated 7, 8 . However, the role of 10 sequence variation arising as a result of post-transcriptional events, such as RNA editing, remains 11 largely unexplored.
13
RNA editing is a modification of double-stranded pre-mRNA that can introduce codon changes in 14 mRNA through insertions, deletions or substitutions of nucleotides and hence can lead to
15
alterations in protein function. Adenosine to inosine (A-to-I) editing is the most common form of
16
RNA editing, affecting the majority of human genes and is highly prevalent in the brain 9, 10 . These 
21
involved in neuronal function 11, 12 . RNA editing has been reported to modulate excitatory responses,
22
permeability of ion channels and other neuronal signaling functions 13, 14 . These sites have been
23
shown to be tightly and dynamically regulated throughout pre-and post-natal human cortical 24 development 15 . Aberrant RNA editing has also been reported in several neurological disorders,
25
including major depression 16 , Alzheimer's disease 17 , and amyotrophic lateral sclerosis 18 .
27
In SCZ, the role of RNA editing in serotonin and glutamate receptors has drawn significant attention 28 largely due to the serotonergic and glutamatergic hypotheses of mood disorders. To this end, RNA
29
editing research in SCZ has so far focused on targeted approaches in serotonin 2C receptor (5- 
30
HT 2C R) and two classes of ionotropic glutamate receptors, 2-amino-3-(3-hydroxy-5-methyl-isoxazol- 
33
>20 different receptor isoforms, each with specific activity 20, 21 . The extent of editing in 5-HT 2C R
34
correlates with functional activity of the receptor and this has been reported in post-mortem brain
35
tissue of individuals with major depression 16 and schizophrenia 21, 22 . Regarding glutamate receptors,
36
AMPA and kainate receptor pre-mRNA undergoes editing at two sites (Q/R and R/G), both of which
37
have functional significance 9, 12 . The Q/R site occurs at a stably high editing rate with 100% editing,
38
whereby loss of editing at this site causes enhanced Ca 2+ permeability, possibly resulting in cellular 39 dysfunction in SCZ 12, 23, 24 . The R/G site is not fully edited, which changes the kinetics of 40 desensitization 25 . However, there are still a limited number of studies measuring RNA editing levels
41
of these receptors in SCZ, and those which have been conducted report on relatively small sample 42 22 mechanism involved in the neurobiology of SCZ.
24

RESULTS
26
Discovery and validation samples 27 28 In order to quantify RNA editing events, we leveraged RNA-sequencing data from post-mortem
29
brain tissue collected and generated on behalf of the CMC. Two brain regions, including the ACC
30
(SCZ=225, Controls=245) and the DLPFC (SCZ=254, Controls=286) were investigated, and
31
together these samples served as the discovery cohort ( Figure S2 ). These samples were also 32 genotyped on the Illumina Infinium HumanOmniExpressExome array. In parallel, we also leveraged 33 a completely separate, non-overlapping cohort consisting of post-mortem DLPFC tissue (SCZ=100,
34
Controls=204) collected and generated on behalf of NIMH HBCC. This second resource served as
35
a validation cohort so as to cross-validate SCZ-related editing events identified from the CMC 36 discovery samples.
38
Overall RNA editing levels in SCZ 39 40 We first asked whether overall levels of RNA editing varied between SCZ and control samples,
41
separately in the ACC and DLPFC. Overall editing levels were computed within each individual
42
sample defined as the percentage of edited nucleotides at all known editing sites. We did not 43 impose any coverage criteria, but instead took all sites into account that were used in this study to 1 obtain the total amount of editing in each sample. Higher levels of overall RNA editing in SCZ cases 2
were observed compared to controls in the ACC and DLFPC (p=0.0001, p=7.2×10 -6 , respectively)
3
( Figure 1A ). Approximately 30% of the variation in overall RNA editing levels was explained by 4 ADAR1 (p=<2.2×10 -16 ), ADAR2 expression explained 17% of variation in overall RNA editing
5
(p=1.2×10 -08 ) and ADAR3 expression had no significant effect (p=0.10) (Figure 1B-C) . In addition,
6
marked increases in overall editing levels were observed within definite genic regions, specifically 7
3'UTR and intergenic regions in SCZ compared to control samples, which replicated across the 8 ACC and DLPFC ( Figure S3A) . Moreover, as previous research has quantified RNA editing levels 9 explicitly in serotonergic and glutamatergic receptors, we also computed overall editing levels in 10 serotonin and glutamate receptor activity genes using a priori defined gene-sets (GO:009589 and
11
GO:0008066, respectively). To this end, higher levels of overall editing were found in glutamate
12
receptors in SCZ cases relative to controls in the ACC (p=0.0004) and DLPFC (p=0.001), while no 13 significant differences were found in the levels of overall editing in serotonin receptors ( Figure   14 S3B). Expression of ADAR1 and ADAR2 were also significantly higher in SCZ compared to control 15 samples ( Figure S3C -E). Importantly, these observations were collectively and robustly reproduced 16 in our independent, non-overlapping DLPFC validation cohort, which together highlight higher
17
overall levels of RNA editing in SCZ, especially within 3'UTR and intergenic regions, as well as
18
within genes encoding glutamatergic receptors. 
19
FIGURE 1
Figure 1.
4
We found no associations between overall RNA editing levels with medication or dosage ( Figure   5 S4), indicating that antipsychotic treatments likely do not have a strong effect on the amount of 6 overall RNA editing observed in SCZ cases.
8
Discovery of altered RNA editing sites in SCZ 9 10 We next set out to identify RNA editing sites associated with SCZ by testing if the degree of RNA 
24
Characterization of differentially edited sites 25 26 Differentially edited sites derived from discovery (ACC and DLPFC) and validation (DLPFC) 
32
We also examined whether these differentially edited sites map to genes with specific 33 developmental expression profiles using gene expression data from the BrainSpan Project and
34
found that differentially edited sites in SCZ consistently mapped to genes that are predominately
35
postnatally biased in expression ( Figure S9 ). These genes were found to peak in brain expression 36 during young and middle adulthood, developmental windows when SCZ often becomes clinically 1 recognizable.
3
As these sites share several sequence and functional features, we explored whether differential 4 editing sites may share a common sequence motif potentially important for editome recognition
5
(20±nt centered on targeted A nucleotide). Consistent and strong enrichment was found for a 10-nt 6 motif (CTGGGATTACA) in region adjacent to most differential editing sites located in 3'UTR regions
7
( Figure S10 , Table S3 ). This short sequence has been reported to occur frequently within non-8 coding regions and is also found to overlap with fragments of Alu repeat elements. Subsequently,
9
we examined whether differentially edited sites found to share this sequence motif also mapped to 
24
Genes enriched with differential RNA editing in SCZ 25 26 We examined whether any genes contained an enrichment of differentially edited sites beyond what 
39
Genome-wide association studies (GWAS) have also found KCNIP4 to be associated with SCZ,
40
suicidal ideation and attention-deficit/hyperactivity disorder [28] [29] [30] Co-editing networks associate with SCZ
2
Discrete groups of coordinately edited (co-edited) sites were identified and tested for association to 
21
editing in these sites leads to enhanced Ca 2+ permeability and cellular dysfunction, and this has
22
been suggested to play a role in SCZ 23, 24 . NOVA1 is essential for normal postnatal motor function
23
and regulates alternative splicing of multiple inhibitory synaptic targets 32 . NOVA1 has been reported
24
to be dysregulated at the gene level in independent SCZ postmortem brain samples 32 and RNA
25
editing in NOVA1 has been shown to influence protein stability 33 , but has yet to be associated with
26
SCZ.
28 29
To validate these findings, a separate co-editing network was constructed for our DLPFC validation 
40
Moreover, M1h and M4h were both positively associated with ADAR1 and ADAR2 expression.
41
These findings indicate replicated co-editing networks in SCZ across brain regions and cohorts,
42
which together converge on decreased AMPA co-editing networks and increased protein translation 1 modules. 
FIGURE 4
Figure 4. Unsupervised co-editing network analysis. (a) Overlap analysis of co-editing modules identified within the ACC and DLPFC. Unsupervised clustering was used to group modules by module eigengene (ME) values using Pearson's correlation coefficient and Ward's distance method. Significance of overlap was computed using a Fisher exact test corrected for multiple comparisons and colored on a continuous scale (bright red, strongly significant; white, no significance). The number of overlapping sites are displayed in each cell with a significant overlap. (b) Enrichment analysis of differentially edited sites within co-editing networks. (c) Assessment of ME values for modules M1a and M1d (over-edited) and M4a and M4d (under-edited). Differential ME analysis was conducted using a linear model and covarying for age, RIN, PMI, sample site and gender. (d) The top functional enrichment terms and (e) brain cell-type enrichment results for all identified modules, verifying similar functional and cell-type properties of co-editing networks in the ACC and DLPFC. (f) A collection of nonsynonymous sites within SCZ-related
Identification and characterization of brain cis-edQTLs
4
Whole-genome genotype data were available for ACC and DLPFC samples used in our discovery 5 cohort and were imputed using standard techniques, as previously described 7 . Genotype data were 6 used to detect SNPs that have an effect on RNA editing levels (edQTL, editing quantitative trait 7 loci). RNA editing levels from European-ancestry samples (ACC N=360; DLPFC N=421) were 8 adjusted to fit a standard normal distribution and to reduce systematic sources of variation. 
M1d M2d Max-edQTLs in the ACC and DLPFC were enriched within genic elements and noncoding RNAs, 1 particularly within intronic regions, while the corresponding editing sites were also enriched in 2 3'UTR regions ( Figure 5C ). Max-edQTLs edSNPs were also examined for tissue-specific enhancer 
9
In both cases, the alternative allele is unable to pair with the opposite base within the double- 
24
GWAS signatures at four loci comprising seven unique edQTL ( Table S6) . Two of these loci are co- 
DISCUSSION
2
The recent expansion of RNA sequencing data sets has led to the identification of a huge number 3 of RNA editing events, which affect the majority of human genes and is highly prevalent in the brain. Recombination rate (cM/Mb) 
15
The majority of differentially edited sites mapped to 3'UTR regions. As the vast majority of these
16
sites are A-to-I conversions and are located in Alu elements, the stability of the resulting RNA
17
structure is likely to be reduced 34 . Similarly, it is likely that RNA editing is contributing to the 18 modulation of the stability of the folded pre-mRNA secondary structure in SCZ. To this end, lower 19 levels of RNA editing were associated with postsynaptic density and glutamatergic genes as well as 20 kainate and glutamate receptor activity genes (Fig. 2) , likely resulting in lower stability in the 21 double-stranded region after editing at these sites. Importantly, these genes comprise some of the 22 most prominent and well-published genes in SCZ biology, including GRIA2, GRIA3, GRIK1, GRIK2,
23
for which aberrant RNA editing levels have been well documented [23] [24] [25] 35 
34
editing sites in SCZ, which were found predominately spanning its first intron (Fig. 3) . A major 
42
In contrast, higher levels of RNA editing were observed in genes that are essential for translation of RBMA has been shown to control mRNA stability and splicing, translation and is located in the 8 1q21.1 copy-number variation associated with mental retardation, autism spectrum disorder, SCZ
9
and microcephaly [48] [49] [50] . MRPS16 was enriched for differentially edited sites located in its respective 10 3'UTR. Although our study focused on global patterns of A-to-I editing, a concerted approach with 11 these human-specific sites, as they have been conducted in glutamatergic receptors, in the future
12
will provide a more complete understanding of how RNA editing in these genes impact SCZ 13 etiology.
15
We detected that edQTL are widespread in the brain and a substantial portion replicate between 
19
regulatory elements, such as tissue-specific enhancers (Fig. S17) and mapping of RNA editing 20 sites on genes, which predominately postnatally biased in neocortical gene expression (Fig. S9) .
21
Moreover, a fine mapping analysis was conducted between edQTL signatures and disease protein's function substantially [53] [54] . However, lysine residues can be sites of post-translational 33 modification and thereby regulate protein function. We also identified GWAS-edQTL co-localization
34
for ENSA, a gene which belongs to a highly conserved cAMP-regulated phosphoprotein family and
35
is considered an endogenous regulator of ATP-sensitive potassium (K ATP ) channels, which rest at 36 the intersection of cell metabolism and membrane excitability 55 
MATERIALS AND METHODS
2
Identification of RNA editing sites from human RNA-sequencing data 3 4 RNA-sequencing data generated from the human post-mortem ACC and DLPFC were obtained were mapped to human reference genome hg19 using STAR version 2. 14 This approach quantifies the total amount of edited reads and the total amount of un-edited reads, (that is, probability that a read is aligned to multiple locations), probability of misalignment = 0.01
20
(i.e., 99% probability that a read is correctly aligned in the genome), and minimum read coverage
21
per edited site to be 20. The identification of RNA editing sites has previously been reported to be
22
prone to these biases, therefore, it is likely that changing these parameters to be more lenient
23
would increase the number of falsely predicted editing events. We also removed all known single 
34
Identification of RNA editing sites from macaque RNA-sequencing data 35 36 To examine whether drug treatment effects were responsible for overall RNA editing levels 37 observed in SCZ, we computed overall editing derived from an RNA-sequencing study of DLPFC
38
tissue from Rhesus macaque monkeys. Antipsychotic administration, tissue dissection and RNA-
39
sequencing data generation was previously described elsewhere 5 . In brief, subjects were randomly Finally, gene expression data was generated using an identical RNA-sequencing protocol. Raw 4 RNA-sequencing data was aligned to the macaque reference genome and transcriptome (mmul1) 5 using STAR. Next, all well documented RNA editing sites in the RADAR database, which were 6 annotated to the human reference hg19, were lifted over to the macaque reference mmul1 using 7 the R library package rtracklayer 6 . These nucleotide coordinates were used to extract reads from 8 each sample using the same customized perl script and the samtools mpileup function. We also 9
carried out a series of matching thresholds in order to identify a collection of high confidence sites 10 across all samples, as noted above. However, because so few sites were detected across all 11 macaque and human samples, we restricted our comparative approach to measure the influence of 12 medication on overall RNA editing levels, which is a threshold-free approach.
14
Quantifying RNA editing levels 15 16 RNA editing levels were calculated for each sample, as previously described 7 . In brief, we define
17
editing levels as the total number of edited reads at a specific RNA editing site (i.e., reads with G
18
nucleotides) over the total number reads covering the site (i.e, reads with A and G nucleotides). The
19
resulting metric is a continuous measure, ranging from 0 (i.e., a totally un-edited site) to 1 (i.e., a 20 completely edited site). When computing overall RNA editing levels per sample, we did not impose
21
any sequencing coverage criteria, but instead took all known sites from the RADAR database into
22
account that were identified in each sample in our study to obtain the total amount of editing in each
23
sample. In this way, overall RNA editing is defined as the total number of edited reads at all known
24
RNA editing sites over the total number reads covering all sites for each sample. These measures
25
were used to identify relationships between editing levels and SCZ and between editing levels and 26 expression of editing enzymes.
28
Differential RNA editing analysis 29 30 It is possible that RNA editing levels, similar to that observed in gene expression studies 
4
Supervised class prediction methods 5 6 In order to assess cross-validation of the SCZ-related sites, two prediction models were built using 7 the differentially edited sites in the (1) DLPFC and (2) ACC derived from the CMC (here referred to 8 as, training set) to predict case/control status (i.e. SCZ cases from control samples) from withheld 9 DLPFC data derived from the HBCC (here referred to as, test set). Regularized regression models,
10
including ElasticNet, Lasso and Ridge Regression were fit using the glmnet R package 10 . The 11 penalty parameter lambda (λ) was estimated using 10-fold cross validation on each training set 12 using the caret package in R, and ultimately set to lambda.min, the value of λ that yields minimum 13 mean cross-validated error of the regression model. Once the models were fit, they were applied to
14
RNA editing levels from the test set using the predict() function, which calculates the predicted log-
15
odds of diagnostic status. Subsequently, area under the receiver operative curve (ROC) analysis
16
was performed using the pROC package in R 11 . Classification accuracies were reported as area
17
under the curve (AUC) on test samples to assess the precision of the models.
19
Identification of enriched sequence motifs and RNA binding protein sites 20 21 Previous studies suggest that RNA editing events are mediated by RNA-binding proteins that 
41
Genes enriched with differentially edited sites 42 43 In order to identify genes enriched with differentially edited sites, we corrected each gene for gene 
6
Co-editing network analysis 7 8 To identify sites that are co-edited across SCZ and control samples, we applied unsupervised 9 weighted gene co-expression network analysis (WGCNA) 14 . Signed networks were constructed for 10 the CMC-derived ACC and DLPFC samples separately, and then again using HBCC-derived 
28
Gene set and cell type enrichment analyses 29 30 All differentially edited sites passing a multiple test corrected P-value <0.05 and all co-editing 31 network modules were subjected to functional annotation. The ToppFunn module of ToppGene
32
Suite software 15 (https://toppgene.cchmc.org/) was used to assess enrichment of GO ontology 33 terms relevant to cellular components, molecular factors, biological processes and metabolic
34
pathways using a one-tailed hyper-geometric distribution with a Bonferroni correction. A minimum of 35 a three-gene overlap per gene set was necessary to be allowed for testing. Subsequently, modules
36
were tested for over-representation of CNS cell type specific markers collected from a previously 37 conducted single cell RNA-sequencing study 16 . In order for a gene to be labeled cell type specific,
38
each marker required a minimum log 2 expression of 1.4 units and a difference of 0.8 units above
39
the next most abundance cell type measurement, as previously shown. Over-representation of cell
40
type markers within co-editing modules was analyzed using a one-sided Fisher exact test to assess 41 the statistical significance. All P-values, from all gene sets and modules, were adjusted for multiple testing using the BH procedure. We required an adjusted P-value <0.05 to claim that a cell type is 1 enriched within a module.
3
BrainSpan developmental gene set enrichment analysis 4 5 BrainSpan developmental RNA-seq data (www.brainspan.org) were summarized to GENCODE10 
